<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Liu Z</submitter><pubmed_abstract>Thyroid associated ophthalmopathy (TAO), characterized by T cell infiltration and orbital fibroblast activation, is an organ-specific autoimmune disease which is still short of effective and safety therapeutic drugs. The PD-1/PD-L1 pathway has been reported hindering the progression of Graves' disease to some extent by inhibiting T cell activity, and tumor therapy with a PD-1 inhibitor caused some adverse effects similar to the symptoms of TAO. These findings suggest that the PD-1/PD-L1 pathway may be associated with the pathogenesis of TAO. However, it remains unknown whether the PD-1/PD-L1 pathway is involved in orbital fibroblast activation. Here, we show that orbital fibroblasts from patients with TAO do not express PD-L1. Based on &lt;i>in vitro&lt;/i> OF-T cell co-culture system, exogenous</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>849480</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9128409</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>PD-L1 Inhibits T Cell-Induced Cytokines and Hyaluronan Expression &lt;i>via&lt;/i> the CD40-CD40L Pathway in Orbital Fibroblasts From Patients With Thyroid Associated Ophthalmopathy.</pubmed_title><pmcid>PMC9128409</pmcid><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Gong Q</pubmed_authors><pubmed_authors>Guan X</pubmed_authors><pubmed_authors>Shi A</pubmed_authors><pubmed_authors>Hao B</pubmed_authors><pubmed_authors>Yuan H</pubmed_authors><pubmed_authors>Bai X</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Liu F</pubmed_authors></additional><is_claimable>false</is_claimable><name>PD-L1 Inhibits T Cell-Induced Cytokines and Hyaluronan Expression &lt;i>via&lt;/i> the CD40-CD40L Pathway in Orbital Fibroblasts From Patients With Thyroid Associated Ophthalmopathy.</name><description>Thyroid associated ophthalmopathy (TAO), characterized by T cell infiltration and orbital fibroblast activation, is an organ-specific autoimmune disease which is still short of effective and safety therapeutic drugs. The PD-1/PD-L1 pathway has been reported hindering the progression of Graves' disease to some extent by inhibiting T cell activity, and tumor therapy with a PD-1 inhibitor caused some adverse effects similar to the symptoms of TAO. These findings suggest that the PD-1/PD-L1 pathway may be associated with the pathogenesis of TAO. However, it remains unknown whether the PD-1/PD-L1 pathway is involved in orbital fibroblast activation. Here, we show that orbital fibroblasts from patients with TAO do not express PD-L1. Based on &lt;i>in vitro&lt;/i> OF-T cell co-culture system, exogenous</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T21:50:23.481Z</modification><creation>2025-02-19T01:23:42.496Z</creation></dates><accession>S-EPMC9128409</accession><cross_references><pubmed>35619700</pubmed><doi>10.3389/fimmu.2022.849480</doi></cross_references></HashMap>